Drawing for REYON

USPTO serial 79298499

REYON

Reviewed by CopyMark Law Group

Reg. 6571385Status 700Renewal
Filing date
Status date
Registration date
Nov 30, 2021
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with REYON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocular surgery; pharmaceutical and veterinary preparations acting on the central nervous system; pharmaceutical and veterinary preparations for the prevention of osteoporosis; pharmaceutical and veterinary preparations for use in urology; pharmaceutical and veterinary preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of therapeutic agents; pharmaceutical and veterinary preparations for use in the anesthesia; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for the peripheral nervous system; pharmaceutical and veterinary preparations for digestive organs; pharmaceutical and veterinary preparations for anti-fungal treatment; nutraceutical preparations for therapeutic or medical purposes; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs; all aforementioned goods sold only to hospitals or other healthcare institutions and to pharmaceutical companiesACTIVE
035Wholesale store services featuring dietary supplements for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring drugs for medical purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring medicines for human purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; business intermediary services relating to mail order by telecommunications, namely, mail order pharmacy services for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring analgesics for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companiesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
May 20, 2022FIMPFINAL DISPOSITION PROCESSED
Feb 28, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2021RFNTREFUSAL PROCESSED BY IB
Feb 4, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2021RFRRREFUSAL PROCESSED BY MPU
Jan 22, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2021DOCKASSIGNED TO EXAMINER
Dec 4, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Nov 30, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance